The association of gamma-glutamyltransferase and C-reactive protein with IFG/IGT in Chinese adults in Qingdao, China

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1658-1661

  Sun, Jianping ^a,b   Ren, J ^b,c   Pang, Z C ^b   Gao, W G ^d,e,f   Nan, H R ^g   Wang, S J ^b   Zhang, L ^d,e,f   Qiao, Q ^d,e  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b Qingdao Municipal Centre for Disease Control and Prevention   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f Qingdao Endocrinology and Diabetes Institute   (China)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C reactive protein; Gamma glutamyltransferase; Impaired fasting glucose; Impaired glucose tolerance

Indexed keywords

C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINA; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME BLOOD LEVEL; FAMILY HISTORY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 79959300609     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.019     Document Type: Article

References (20)

1. Whitfield J.B. Gamma glutamyltransferase. Crit Rev Clin Lab Sci 2001, 38:263-355.
2. Nemesanszky E., Lott J.A. γ-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem 1985, 31:797-803.
3. Lee D.H., Ha M.H., Kim J.H., et al. γ-Glutamyltransferase and diabetes-a 4year follow-up study. Diabetologia 2003, 46:359-364.
4. Lee D.H., Silventoinen K., Jacobs D.R., Jousilahti P., Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004, 89:5410-5414.
5. Meisinger C., Lowel H., Heier M., Schneider A., Thorand B. KORA Study Group. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005, 258:527-535.
6. Andre P., Balkau B., Born C., Charles M.A., Eschwege E. D.E.S.I.R. Study Group. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 2006, 49:2599-2603.
7. Wen J., Liang Y., Wang F., et al. C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. Clinica Chimica Acta 2009, 411:198-203.
8. Nakanishi N., Nishina K., Li W., Sato M., Suzuki K., Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003, 254:287-295.
9. Nannipieri M., Gonzales C., Baldi S., et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 2005, 28:1757-1762.
10. Bianchi C., Penno G., Crisci I., et al. Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation. Diabetes Metab Res Rev 2010, 26:181-186.
11. Kathryn C.B., Neison M.S., Sinney C.F., Eward D., Lam T.H., Karen S.L. C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 2003, 26:2323-2328.
12. Nakanishi N., Shiraishi T., Wada M. Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Res Clin Pract 2005, 69:88-98.
13. Lin J., Zhang M., Song F., et al. Association between C-reactive protein and pre-diabeic status in a Chinese Han clinical population. Diabetes Metab Res Rev 2009, 25:219-223.
14. Hoelzel W., Weykamp C., Jeppsson J.O., et al. IFCC reference system for measurement of haemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004 Jan, 50:166-174.
15. WHO/ IDF Consultation Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/International Diabetes Federation Consultation 2006, the World Health Organization Document Production Services, Geneva.
16. Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
17. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
18. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
19. Song F., Jia W., Yao Y., et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 2007, 112:599-606.
20. Lee C.C., Adler A.I., Sandhu M.S., et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 2009, 52:1040-1047.